Other Kidney and Urinary Tract Procedures DRG 675 Reimbursement

DRG 675 encompasses other kidney and urinary tract procedures performed without a Complication or Comorbidity or Major Complication or Comorbidity and represents lower-complexity genitourinary interventions relevant to inpatient billing. It matters for inpatient reimbursement because it establishes a payment category reflecting typical resource use for these procedures under Medicare payment systems.

DRG 675 Overview

DRG 675 covers hospital stays for patients undergoing various non-major kidney and urinary tract procedures without associated Complication or Comorbidity or Major Complication or Comorbidity. Typical cases include diagnostic or minor therapeutic genitourinary procedures that do not require extensive resources. This Diagnosis-Related Group is important for Medicare reimbursement because it groups similar resource use and informs the prospective payment for inpatient stays. Understanding the clinical scope helps hospitals anticipate payment relative to more complex kidney and urinary tract procedure groups.

Studies evaluating minimally invasive versus open surgical approaches for non-complex kidney and urinary tract procedures (e.g., partial nephrectomy for small renal masses, ureteral reconstructive procedures) focusing on intraoperative metrics, short-term complications, and length of stay. These trials enroll adult patients admitted for elective or urgent non-complicated urinary tract surgeries without major comorbid complications, comparing recovery time, perioperative resource use, and complication rates. Findings are relevant to providers for procedure selection and to payers for understanding cost drivers and potential reductions in hospital days and readmissions for cases classified in this DRG.
Comparative effectiveness research assessing different perioperative care pathways (enhanced recovery after surgery protocols versus standard care) for patients undergoing kidney and urinary tract procedures without CC/MCC, measuring opioid use, time to mobilization, complication rates, and discharge disposition. These studies typically include a broad inpatient population without major complications but at risk for prolonged recovery, and may stratify by age or baseline renal function to identify subgroups who benefit most. Results inform clinicians and hospitals on best practices to shorten LOS and reduce complications, and help payers model potential savings from standardized pathways in this DRG.
Post-discharge outcomes and health services research tracking readmissions, outpatient complications, functional recovery, and patient-reported outcomes after index hospitalizations for other kidney and urinary tract procedures without CC/MCC. These cohort studies follow patients across the 30–90 day post-discharge period to identify predictors of readmission, outpatient resource use, and long-term renal or urinary function. Insights help providers target follow-up care to high-risk patients and enable payers to estimate downstream costs and design transitional care programs to reduce avoidable utilization for this patient group.

Studies evaluating minimally invasive versus open surgical approaches for non-complex kidney and urinary tract procedures (e.g., partial nephrectomy for small renal masses, ureteral reconstructive procedures) focusing on intraoperative metrics, short-term complications, and length of stay. These trials enroll adult patients admitted for elective or urgent non-complicated urinary tract surgeries without major comorbid complications, comparing recovery time, perioperative resource use, and complication rates. Findings are relevant to providers for procedure selection and to payers for understanding cost drivers and potential reductions in hospital days and readmissions for cases classified in this DRG.
Comparative effectiveness research assessing different perioperative care pathways (enhanced recovery after surgery protocols versus standard care) for patients undergoing kidney and urinary tract procedures without CC/MCC, measuring opioid use, time to mobilization, complication rates, and discharge disposition. These studies typically include a broad inpatient population without major complications but at risk for prolonged recovery, and may stratify by age or baseline renal function to identify subgroups who benefit most. Results inform clinicians and hospitals on best practices to shorten LOS and reduce complications, and help payers model potential savings from standardized pathways in this DRG.
Post-discharge outcomes and health services research tracking readmissions, outpatient complications, functional recovery, and patient-reported outcomes after index hospitalizations for other kidney and urinary tract procedures without CC/MCC. These cohort studies follow patients across the 30–90 day post-discharge period to identify predictors of readmission, outpatient resource use, and long-term renal or urinary function. Insights help providers target follow-up care to high-risk patients and enable payers to estimate downstream costs and design transitional care programs to reduce avoidable utilization for this patient group.

OpenPayer

Summary & Overview

Other Kidney and Urinary Tract Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 675 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes